The study aimed to compare the prevalence of sarcopenia among people living with HIV using two different definitions from EWGSOP1 and EWGSOP2, focusing on low muscle strength as the primary criterion in the newer definition.
A total of 302 participants were evaluated, revealing a sarcopenia prevalence of 4.3% with EWGSOP1 compared to only 1.0% with EWGSOP2, highlighting significant differences in diagnosis rates.
The study found fair agreement between the two definitions and observed a medium correlation between different muscle strength tests, indicating inconsistencies in diagnosing sarcopenia based on varying criteria.